Although our recent studies suggest GSK-3 as an important factor of NF-κB-mediated cancer cell survival and proliferation in pancreatic cancer and CLL (Ougolkov et al, 2006, 2007), the role of GSK-3 in the proliferation and survival of RCC is unknown. This evidence concerns the gene NFKB1 and renal cell carcinoma.